Fsd Pharma Stock News

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc announced that its wholly-owned Lucid Psycheceuticals Inc subsidiary has filed a provisional patent application on novel formulations of palmitoylethanolamide (

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc has announced that it has submitted Investigation New Drug applications to the US Food and Drug Administration (FDA) and Health Canada for its planned Phase 2 c

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc announced that it has closed the sale of its former cannabis processing facility in Cobourg, Ontario, Canada for gross proceeds of $16.4 million in cash.  The f

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc. announced that it is expanding its management and advisory teams.

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we mak

Gainers Inspirato Incorporated (NASDAQ: ISPO ) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI ) jumped 45.4% to settle at $0.5979 on Friday. EF Hutton recently initiated coverage on the stock with a Buy rating and a $2 price target. CarGurus, Inc. (NASDAQ: CARG ) shares gained 44% to close at $46.44 after the company reported better-than-expected Q4 results. Farfetch Limited (NYSE: FTCH ) climbed 39.4% to close at $20.92 after the company reported better-than-expected Q4 EPS results. TD Holdings, Inc. (NASDAQ: GLG ) gained 38.9% to settle at $0.25 amid overall market strength as investors react to the ongoing Russia-Ukraine conflict. KAR Auction Services, Inc. (NYSE: KAR ) shares climbed 38.4% to close at $18.94 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral. Imperial Petroleum Inc. (NASDAQ: IMPP ) gained 33.8% to close at $2.10. Universal Security Instruments, Inc. (NYSE: UUU ) climbed 32.9% to close at $3.96 after the company reported a joint merger deal with Infinite Reality.

FSD Pharma Inc. (NASDAQ: HUGE ) (CSE:HUGE) (FRA:0K9A) has entered into a firm agreement in connection with the sale of its former cannabis processing facility located in Cobourg, Ontario and the 64.43 acre property on which the facility is located. In consideration for the purchase of the facility, the purchaser has agreed to pay a cash sum of CAD$16.5 million ( US$12.9 million) , including a deposit of CAD$0.66 million. The deposit was received by the company … Full story available on Benzinga.com

FSD Pharma (HUGE) has signed a deal to sell its former cannabis processing facility in Cobourg, Ontario for C$16.5M in cash, including a C$660,000 deposit.The transaction will close on…

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. FSD Pharma (NASDAQ: HUGE ) (CSE: HUGE) (FRA: 0K9), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced the launch of its newly designed website . According to the update, the new site conveys the companys emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. We have strategically assembled a team of scientists to help develop our powerful pipeline of next-generation therapeutics, said Anthony Durkacz, interim CEO of FSD Pharma. With some of the greatest minds in neurology and inflammation working together to advance our promising therapeutic compounds, and supported by a strong balance sheet, we believe that we are very well positioned to continue the advancement of our three leading drug candidates: Lucid-MS, Lucid-PSYCH and FSD-PEA.

New Website Shares FSD''s Unique Drug Pipeline and Vision to Improve the Quality of Life for Patients Suffering from Brain & Inflammatory Disorders FSD Pharma Inc. (NASDAQ: HUGE ) (CSE: HUGE ) (FRA: 0K9A) (" FSD Pharma " or the " Company "), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website. The new site conveys the Company''s emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. To view the website, please visit www.fsdpharma.com . "We have strategically assembled a team of scientists to help develop our powerful pipeline of next-generation therapeutics," said Anthony Durkacz, Interim CEO of FSD Pharma. "With some of the greatest minds in neurology and inflammation working together to advance our promising therapeutic compounds, and supported by a strong balance sheet, we believe that we are very well positioned to continue the advancement of our three leading drug candidates: Lucid-MS, Lucid-PSYCH and FSD-PEA.

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a p

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc said its board of directors has authorized the repurchase by the company of up to 2 million of its subordinate Class B voting shares, being approximately 5% of

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc said its board of directors has authorized the repurchase by the company of up to 2 million of its subordinate Class B voting shares, being approximately 5% of

Shares of FSD Pharma Inc. (NASDAQ:HUGE) dropped 0.9% during mid-day trading on Wednesday . The stock traded as low as $1.07 and last traded at $1.13. Approximately 230,091 shares traded hands during trading, a decline of 83% from the average daily volume of 1,348,442 shares. The stock had previously closed at $1.14. The stock has []